Occupational allergy to glucagon-like peptide-1 receptor agonist precurser

被引：0
|
作者：
Johnsen, C. R. [1 ]
Rudkjoebing, L. A. [2 ]
Bartko, E. [3 ]
机构：
[1] Gentofte Univ Hosp, Hellerup, Denmark
[2] Holbaek Cent Hosp, Holbaek, Denmark
[3] Allergy Clin, Dermatol & Allergy, Hellerup, Denmark
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
100324
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Glucagon-like peptide-1 receptor agonist use is associated with lower serum periostin
    Foer, Dinah
    Beeler, Patrick E.
    Cui, Jing
    Snyder, William E.
    Mashayekhi, Mona
    Nian, Hui
    Luther, James M.
    Karlson, Elizabeth W.
    Boyce, Joshua A.
    Cahill, Katherine N.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (04): : 469 - 473
  • [42] A glucagon-like peptide-1 receptor agonist and an antagonist modify macronutrient selection by rats
    Peters, CT
    Choi, YH
    Brubaker, PL
    Anderson, GH
    JOURNAL OF NUTRITION, 2001, 131 (08): : 2164 - 2170
  • [43] The Role of a Glucagon-Like Peptide-1 Receptor Agonist in Visceral and Subcutaneous Fat Redistribution
    Zhao, Li
    Zhu, Chunfang
    Lu, Meng
    Chen, Chi
    Chen, Yi
    Wang, Ningjian
    Lu, Yingli
    DIABETES, 2018, 67
  • [44] Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist
    Parker, Victoria E. R.
    Robertson, Darren
    Wang, Tao
    Hornigold, David C.
    Petrone, Marcella
    Cooper, Aidan T.
    Posch, Maximilian G.
    Heise, Tim
    Plum-Moerschel, Leona
    Schlichthaar, Heike
    Klaus, Beate
    Ambery, Philip D.
    Meier, Juris J.
    Hirshberg, Boaz
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (03): : 803 - 820
  • [45] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
    De Block, Christophe E. M.
    Dirinck, Eveline
    Verhaegen, Ann
    Van Gaal, Luc F.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 788 - 805
  • [46] Can epicardial fat glucagon-like peptide-1 receptor open up to the cardiovascular benefits of glucagon-like peptide-1 analogues?
    Iacobellis, Gianluca
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (03): : 224 - 225
  • [47] Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism
    Hansen, Morten S. S.
    Tencerova, Michaela
    Frolich, Jacob
    Kassem, Moustapha
    Frost, Morten
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (01) : 25 - 37
  • [48] Glucagon-like peptide-1 and satiety
    S. R. Bloom
    Nature, 1997, 385 : 214 - 214
  • [49] The treatment of hidradenitis suppurativa with the glucagon-like peptide-1 agonist liraglutide
    Jennings, L.
    Nestor, L.
    Molloy, O.
    Hughes, R.
    Moriarty, B.
    Kirby, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (03) : 858 - 859
  • [50] Glucagon-Like Peptide-1 and Diabetes
    Monami, Matteo
    EXPERIMENTAL DIABETES RESEARCH, 2011,
12345